Simply Wall St.
One Lifecore Biomedical Insider Raised Their Stake In The Previous Year
📊
AI Sentiment
Positive
7/10
- Home
- LFCR
as of 12-24-2025 12:41pm EST
$8.30
+$0.23
+2.92%
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | CHASKA |
| Market Cap: | 296.0M | IPO Year: | N/A |
| Target Price: | $6.00 | AVG Volume (30 days): | 172.3K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.76 - $8.85 | Next Earning Date: | 01-02-2026 |
| Revenue: | $128,867,000 | Revenue Growth: | 0.47% |
| Revenue Growth (this year): | 2.8% | Revenue Growth (next year): | 11.51% |
Latest Lifecore Biomedical Inc. News
LFCR Breaking Stock News: Dive into LFCR Ticker-Specific Updates for Smart Investing
GlobeNewswire
Lifecore Biomedical to be Added to Nasdaq Biotech Index
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Lifecore Biomedical Signs CDMO Agreement With Global Pharma Customer
📊
AI Sentiment
Positive
7/10
GlobeNewswire
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer
📈
AI Sentiment
Highly Positive
9/10
Compare LFCR vs Leading Stocks
See how LFCR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LFCR Lifecore Biomedical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.